ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global GLP-1 Weight Loss Injection Market Research Report 2026
Published Date: 2026-01-19
|
Report Code: QYRE-Auto-34N18433
Home | Market Reports | Beauty & Fitness| Weight Loss
Global GLP 1 Weight Loss Injection Market Research Report 2024
BUY CHAPTERS

Global GLP-1 Weight Loss Injection Market Research Report 2026

Code: QYRE-Auto-34N18433
Report
2026-01-19
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Gan & Lee Pharmaceuticals
CSPC Pharmaceutical Group
Hansoh Pharmaceuticals
Wanbang Biopharma
Sihuan Pharmaceuticals
IMEIK
Gan & Lee Pharmaceuticals

GLP-1 Weight Loss Injection Market Size

The global GLP-1 Weight Loss Injection market was valued at US$ 1181 million in 2025 and is anticipated to reach US$ 2458 million by 2032, at a CAGR of 11.2% from 2026 to 2032.

GLP-1 Weight Loss Injection Market

GLP-1 Weight Loss Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GLP-1 Weight Loss Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
GLP-1 (glucagon-like peptide-1) weight loss injection is a weight loss drug developed based on GLP-1 or its analogs. It is injected to simulate or enhance the physiological effects of GLP-1 to help people lose weight. GLP-1 (glucagon-like peptide-1) weight loss injection can help people suppress appetite, slow down gastric emptying, promote fat metabolism, etc. At present, there are many GLP-1 weight loss drugs on the market, such as liraglutide, benaglutide, semaglutide and Tirzepatide.
The North American market for GLP-1 Weight Loss Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for GLP-1 Weight Loss Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of GLP-1 Weight Loss Injection include Novo Nordisk, Eli Lilly, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Gan & Lee Pharmaceuticals, CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global GLP-1 Weight Loss Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GLP-1 Weight Loss Injection. The GLP-1 Weight Loss Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GLP-1 Weight Loss Injection market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GLP-1 Weight Loss Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of GLP-1 Weight Loss Injection Market Report

Report Metric Details
Report Name GLP-1 Weight Loss Injection Market
Accounted market size in 2025 US$ 1181 million
Forecasted market size in 2032 US$ 2458 million
CAGR 11.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Liraglutide
  • Semaglutide
  • Tirzepatide
  • Benaglutide
  • Others
by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novo Nordisk, Eli Lilly, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Gan & Lee Pharmaceuticals, CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for GLP-1 Weight Loss Injection manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines GLP-1 Weight Loss Injection sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is GLP-1 Weight Loss Injection Market growing?

Ans: The GLP-1 Weight Loss Injection Market witnessing a CAGR of 11.2% during the forecast period 2026-2032.

What is the GLP-1 Weight Loss Injection Market size in 2032?

Ans: The GLP-1 Weight Loss Injection Market size in 2032 will be US$ 2458 million.

Who are the main players in the GLP-1 Weight Loss Injection Market report?

Ans: The main players in the GLP-1 Weight Loss Injection Market are Novo Nordisk, Eli Lilly, Huadong Medicine, Borui Pharmaceuticals, Hengrui Medicine, Innovent Biologics, Shanghai Benemae Biopharmaceuticals Co., Ltd., Gan & Lee Pharmaceuticals, CSPC Pharmaceutical Group, Hansoh Pharmaceuticals, Wanbang Biopharma, Sihuan Pharmaceuticals, Imeik

What are the Application segmentation covered in the GLP-1 Weight Loss Injection Market report?

Ans: The Applications covered in the GLP-1 Weight Loss Injection Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the GLP-1 Weight Loss Injection Market report?

Ans: The Types covered in the GLP-1 Weight Loss Injection Market report are Liraglutide, Semaglutide, Tirzepatide, Benaglutide, Others

1 GLP-1 Weight Loss Injection Market Overview
1.1 Product Definition
1.2 GLP-1 Weight Loss Injection by Type
1.2.1 Global GLP-1 Weight Loss Injection Market Value by Type: 2025 vs 2032
1.2.2 Liraglutide
1.2.3 Semaglutide
1.2.4 Tirzepatide
1.2.5 Benaglutide
1.2.6 Others
1.3 GLP-1 Weight Loss Injection by Application
1.3.1 Global GLP-1 Weight Loss Injection Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global GLP-1 Weight Loss Injection Market Size Estimates and Forecasts
1.4.1 Global GLP-1 Weight Loss Injection Revenue 2021–2032
1.4.2 Global GLP-1 Weight Loss Injection Sales 2021–2032
1.4.3 Global GLP-1 Weight Loss Injection Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GLP-1 Weight Loss Injection Market Competition by Manufacturers
2.1 Global GLP-1 Weight Loss Injection Sales Market Share by Manufacturers (2021–2026)
2.2 Global GLP-1 Weight Loss Injection Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GLP-1 Weight Loss Injection Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GLP-1 Weight Loss Injection, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GLP-1 Weight Loss Injection, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GLP-1 Weight Loss Injection, Product Types and Applications
2.7 Global Key Manufacturers of GLP-1 Weight Loss Injection, Date of Entry into the Industry
2.8 Global GLP-1 Weight Loss Injection Market Competitive Situation and Trends
2.8.1 Global GLP-1 Weight Loss Injection Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GLP-1 Weight Loss Injection Players Market Share by Revenue
2.8.3 Global GLP-1 Weight Loss Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GLP-1 Weight Loss Injection Market Scenario by Region
3.1 Global GLP-1 Weight Loss Injection Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GLP-1 Weight Loss Injection Sales by Region: 2021–2032
3.2.1 Global GLP-1 Weight Loss Injection Sales by Region: 2021–2026
3.2.2 Global GLP-1 Weight Loss Injection Sales by Region: 2027–2032
3.3 Global GLP-1 Weight Loss Injection Revenue by Region: 2021–2032
3.3.1 Global GLP-1 Weight Loss Injection Revenue by Region: 2021–2026
3.3.2 Global GLP-1 Weight Loss Injection Revenue by Region: 2027–2032
3.4 North America GLP-1 Weight Loss Injection Market Facts & Figures by Country
3.4.1 North America GLP-1 Weight Loss Injection Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GLP-1 Weight Loss Injection Sales by Country (2021–2032)
3.4.3 North America GLP-1 Weight Loss Injection Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GLP-1 Weight Loss Injection Market Facts & Figures by Country
3.5.1 Europe GLP-1 Weight Loss Injection Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GLP-1 Weight Loss Injection Sales by Country (2021–2032)
3.5.3 Europe GLP-1 Weight Loss Injection Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GLP-1 Weight Loss Injection Market Facts & Figures by Region
3.6.1 Asia Pacific GLP-1 Weight Loss Injection Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GLP-1 Weight Loss Injection Sales by Region (2021–2032)
3.6.3 Asia Pacific GLP-1 Weight Loss Injection Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GLP-1 Weight Loss Injection Market Facts & Figures by Country
3.7.1 Latin America GLP-1 Weight Loss Injection Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GLP-1 Weight Loss Injection Sales by Country (2021–2032)
3.7.3 Latin America GLP-1 Weight Loss Injection Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GLP-1 Weight Loss Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa GLP-1 Weight Loss Injection Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (2021–2032)
3.8.3 Middle East and Africa GLP-1 Weight Loss Injection Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GLP-1 Weight Loss Injection Sales by Type (2021–2032)
4.1.1 Global GLP-1 Weight Loss Injection Sales by Type (2021–2026)
4.1.2 Global GLP-1 Weight Loss Injection Sales by Type (2027–2032)
4.1.3 Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021–2032)
4.2 Global GLP-1 Weight Loss Injection Revenue by Type (2021–2032)
4.2.1 Global GLP-1 Weight Loss Injection Revenue by Type (2021–2026)
4.2.2 Global GLP-1 Weight Loss Injection Revenue by Type (2027–2032)
4.2.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021–2032)
4.3 Global GLP-1 Weight Loss Injection Price by Type (2021–2032)
5 Segment by Application
5.1 Global GLP-1 Weight Loss Injection Sales by Application (2021–2032)
5.1.1 Global GLP-1 Weight Loss Injection Sales by Application (2021–2026)
5.1.2 Global GLP-1 Weight Loss Injection Sales by Application (2027–2032)
5.1.3 Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021–2032)
5.2 Global GLP-1 Weight Loss Injection Revenue by Application (2021–2032)
5.2.1 Global GLP-1 Weight Loss Injection Revenue by Application (2021–2026)
5.2.2 Global GLP-1 Weight Loss Injection Revenue by Application (2027–2032)
5.2.3 Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021–2032)
5.3 Global GLP-1 Weight Loss Injection Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novo Nordisk
6.1.1 Novo Nordisk Company Information
6.1.2 Novo Nordisk Description and Business Overview
6.1.3 Novo Nordisk GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novo Nordisk GLP-1 Weight Loss Injection Product Portfolio
6.1.5 Novo Nordisk Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Company Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Eli Lilly GLP-1 Weight Loss Injection Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Huadong Medicine
6.3.1 Huadong Medicine Company Information
6.3.2 Huadong Medicine Description and Business Overview
6.3.3 Huadong Medicine GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Huadong Medicine GLP-1 Weight Loss Injection Product Portfolio
6.3.5 Huadong Medicine Recent Developments/Updates
6.4 Borui Pharmaceuticals
6.4.1 Borui Pharmaceuticals Company Information
6.4.2 Borui Pharmaceuticals Description and Business Overview
6.4.3 Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Borui Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
6.4.5 Borui Pharmaceuticals Recent Developments/Updates
6.5 Hengrui Medicine
6.5.1 Hengrui Medicine Company Information
6.5.2 Hengrui Medicine Description and Business Overview
6.5.3 Hengrui Medicine GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Hengrui Medicine GLP-1 Weight Loss Injection Product Portfolio
6.5.5 Hengrui Medicine Recent Developments/Updates
6.6 Innovent Biologics
6.6.1 Innovent Biologics Company Information
6.6.2 Innovent Biologics Description and Business Overview
6.6.3 Innovent Biologics GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Innovent Biologics GLP-1 Weight Loss Injection Product Portfolio
6.6.5 Innovent Biologics Recent Developments/Updates
6.7 Shanghai Benemae Biopharmaceuticals Co., Ltd.
6.7.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
6.7.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
6.7.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product Portfolio
6.7.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
6.8 Gan & Lee Pharmaceuticals
6.8.1 Gan & Lee Pharmaceuticals Company Information
6.8.2 Gan & Lee Pharmaceuticals Description and Business Overview
6.8.3 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
6.8.5 Gan & Lee Pharmaceuticals Recent Developments/Updates
6.9 CSPC Pharmaceutical Group
6.9.1 CSPC Pharmaceutical Group Company Information
6.9.2 CSPC Pharmaceutical Group Description and Business Overview
6.9.3 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product Portfolio
6.9.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.10 Hansoh Pharmaceuticals
6.10.1 Hansoh Pharmaceuticals Company Information
6.10.2 Hansoh Pharmaceuticals Description and Business Overview
6.10.3 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
6.10.5 Hansoh Pharmaceuticals Recent Developments/Updates
6.11 Wanbang Biopharma
6.11.1 Wanbang Biopharma Company Information
6.11.2 Wanbang Biopharma Description and Business Overview
6.11.3 Wanbang Biopharma GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Wanbang Biopharma GLP-1 Weight Loss Injection Product Portfolio
6.11.5 Wanbang Biopharma Recent Developments/Updates
6.12 Sihuan Pharmaceuticals
6.12.1 Sihuan Pharmaceuticals Company Information
6.12.2 Sihuan Pharmaceuticals Description and Business Overview
6.12.3 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product Portfolio
6.12.5 Sihuan Pharmaceuticals Recent Developments/Updates
6.13 Imeik
6.13.1 Imeik Company Information
6.13.2 Imeik Description and Business Overview
6.13.3 Imeik GLP-1 Weight Loss Injection Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Imeik GLP-1 Weight Loss Injection Product Portfolio
6.13.5 Imeik Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GLP-1 Weight Loss Injection Industry Chain Analysis
7.2 GLP-1 Weight Loss Injection Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GLP-1 Weight Loss Injection Production Mode & Process Analysis
7.4 GLP-1 Weight Loss Injection Sales and Marketing
7.4.1 GLP-1 Weight Loss Injection Sales Channels
7.4.2 GLP-1 Weight Loss Injection Distributors
7.5 GLP-1 Weight Loss Injection Customer Analysis
8 GLP-1 Weight Loss Injection Market Dynamics
8.1 GLP-1 Weight Loss Injection Industry Trends
8.2 GLP-1 Weight Loss Injection Market Drivers
8.3 GLP-1 Weight Loss Injection Market Challenges
8.4 GLP-1 Weight Loss Injection Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Novo Nordisk
Eli Lilly
Huadong Medicine
Borui Pharmaceuticals
Hengrui Medicine
Innovent Biologics
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Gan & Lee Pharmaceuticals
CSPC Pharmaceutical Group
Hansoh Pharmaceuticals
Wanbang Biopharma
Sihuan Pharmaceuticals
IMEIK
Gan & Lee Pharmaceuticals
List of Tables
 Table 1. Global GLP-1 Weight Loss Injection Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global GLP-1 Weight Loss Injection Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global GLP-1 Weight Loss Injection Market Competitive Situation by Manufacturers in 2025
 Table 4. Global GLP-1 Weight Loss Injection Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global GLP-1 Weight Loss Injection Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global GLP-1 Weight Loss Injection Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global GLP-1 Weight Loss Injection Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market GLP-1 Weight Loss Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of GLP-1 Weight Loss Injection, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of GLP-1 Weight Loss Injection, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of GLP-1 Weight Loss Injection, Product Types and Applications
 Table 12. Global Key Manufacturers of GLP-1 Weight Loss Injection, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global GLP-1 Weight Loss Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on GLP-1 Weight Loss Injection Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global GLP-1 Weight Loss Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global GLP-1 Weight Loss Injection Sales by Region (K Units), 2021–2026
 Table 18. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2021–2026)
 Table 19. Global GLP-1 Weight Loss Injection Sales by Region (K Units), 2027–2032
 Table 20. Global GLP-1 Weight Loss Injection Sales Market Share by Region (2027–2032)
 Table 21. Global GLP-1 Weight Loss Injection Revenue by Region (US$ Million), 2021–2026
 Table 22. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2021–2026)
 Table 23. Global GLP-1 Weight Loss Injection Revenue by Region (US$ Million), 2027–2032
 Table 24. Global GLP-1 Weight Loss Injection Revenue Market Share by Region (2027–2032)
 Table 25. North America GLP-1 Weight Loss Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America GLP-1 Weight Loss Injection Sales by Country (K Units), 2021–2026
 Table 27. North America GLP-1 Weight Loss Injection Sales by Country (K Units), 2027–2032
 Table 28. North America GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2021–2026
 Table 29. North America GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe GLP-1 Weight Loss Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe GLP-1 Weight Loss Injection Sales by Country (K Units), 2021–2026
 Table 32. Europe GLP-1 Weight Loss Injection Sales by Country (K Units), 2027–2032
 Table 33. Europe GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific GLP-1 Weight Loss Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific GLP-1 Weight Loss Injection Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific GLP-1 Weight Loss Injection Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific GLP-1 Weight Loss Injection Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific GLP-1 Weight Loss Injection Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America GLP-1 Weight Loss Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America GLP-1 Weight Loss Injection Sales by Country (K Units), 2021–2026
 Table 42. Latin America GLP-1 Weight Loss Injection Sales by Country (K Units), 2027–2032
 Table 43. Latin America GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa GLP-1 Weight Loss Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa GLP-1 Weight Loss Injection Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa GLP-1 Weight Loss Injection Revenue by Country (US$ Million), 2027–2032
 Table 50. Global GLP-1 Weight Loss Injection Sales (K Units) by Type (2021–2026)
 Table 51. Global GLP-1 Weight Loss Injection Sales (K Units) by Type (2027–2032)
 Table 52. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2021–2026)
 Table 53. Global GLP-1 Weight Loss Injection Sales Market Share by Type (2027–2032)
 Table 54. Global GLP-1 Weight Loss Injection Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global GLP-1 Weight Loss Injection Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2021–2026)
 Table 57. Global GLP-1 Weight Loss Injection Revenue Market Share by Type (2027–2032)
 Table 58. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Type (2021–2026)
 Table 59. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Type (2027–2032)
 Table 60. Global GLP-1 Weight Loss Injection Sales (K Units) by Application (2021–2026)
 Table 61. Global GLP-1 Weight Loss Injection Sales (K Units) by Application (2027–2032)
 Table 62. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2021–2026)
 Table 63. Global GLP-1 Weight Loss Injection Sales Market Share by Application (2027–2032)
 Table 64. Global GLP-1 Weight Loss Injection Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global GLP-1 Weight Loss Injection Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2021–2026)
 Table 67. Global GLP-1 Weight Loss Injection Revenue Market Share by Application (2027–2032)
 Table 68. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Application (2021–2026)
 Table 69. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Application (2027–2032)
 Table 70. Novo Nordisk Company Information
 Table 71. Novo Nordisk Description and Business Overview
 Table 72. Novo Nordisk GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Novo Nordisk GLP-1 Weight Loss Injection Product
 Table 74. Novo Nordisk Recent Developments/Updates
 Table 75. Eli Lilly Company Information
 Table 76. Eli Lilly Description and Business Overview
 Table 77. Eli Lilly GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Eli Lilly GLP-1 Weight Loss Injection Product
 Table 79. Eli Lilly Recent Developments/Updates
 Table 80. Huadong Medicine Company Information
 Table 81. Huadong Medicine Description and Business Overview
 Table 82. Huadong Medicine GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Huadong Medicine GLP-1 Weight Loss Injection Product
 Table 84. Huadong Medicine Recent Developments/Updates
 Table 85. Borui Pharmaceuticals Company Information
 Table 86. Borui Pharmaceuticals Description and Business Overview
 Table 87. Borui Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Borui Pharmaceuticals GLP-1 Weight Loss Injection Product
 Table 89. Borui Pharmaceuticals Recent Developments/Updates
 Table 90. Hengrui Medicine Company Information
 Table 91. Hengrui Medicine Description and Business Overview
 Table 92. Hengrui Medicine GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Hengrui Medicine GLP-1 Weight Loss Injection Product
 Table 94. Hengrui Medicine Recent Developments/Updates
 Table 95. Innovent Biologics Company Information
 Table 96. Innovent Biologics Description and Business Overview
 Table 97. Innovent Biologics GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Innovent Biologics GLP-1 Weight Loss Injection Product
 Table 99. Innovent Biologics Recent Developments/Updates
 Table 100. Shanghai Benemae Biopharmaceuticals Co., Ltd. Company Information
 Table 101. Shanghai Benemae Biopharmaceuticals Co., Ltd. Description and Business Overview
 Table 102. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Weight Loss Injection Product
 Table 104. Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 105. Gan & Lee Pharmaceuticals Company Information
 Table 106. Gan & Lee Pharmaceuticals Description and Business Overview
 Table 107. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Gan & Lee Pharmaceuticals GLP-1 Weight Loss Injection Product
 Table 109. Gan & Lee Pharmaceuticals Recent Developments/Updates
 Table 110. CSPC Pharmaceutical Group Company Information
 Table 111. CSPC Pharmaceutical Group Description and Business Overview
 Table 112. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. CSPC Pharmaceutical Group GLP-1 Weight Loss Injection Product
 Table 114. CSPC Pharmaceutical Group Recent Developments/Updates
 Table 115. Hansoh Pharmaceuticals Company Information
 Table 116. Hansoh Pharmaceuticals Description and Business Overview
 Table 117. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Hansoh Pharmaceuticals GLP-1 Weight Loss Injection Product
 Table 119. Hansoh Pharmaceuticals Recent Developments/Updates
 Table 120. Wanbang Biopharma Company Information
 Table 121. Wanbang Biopharma Description and Business Overview
 Table 122. Wanbang Biopharma GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Wanbang Biopharma GLP-1 Weight Loss Injection Product
 Table 124. Wanbang Biopharma Recent Developments/Updates
 Table 125. Sihuan Pharmaceuticals Company Information
 Table 126. Sihuan Pharmaceuticals Description and Business Overview
 Table 127. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Sihuan Pharmaceuticals GLP-1 Weight Loss Injection Product
 Table 129. Sihuan Pharmaceuticals Recent Developments/Updates
 Table 130. Imeik Company Information
 Table 131. Imeik Description and Business Overview
 Table 132. Imeik GLP-1 Weight Loss Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Imeik GLP-1 Weight Loss Injection Product
 Table 134. Imeik Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. GLP-1 Weight Loss Injection Distributors List
 Table 138. GLP-1 Weight Loss Injection Customers List
 Table 139. GLP-1 Weight Loss Injection Market Trends
 Table 140. GLP-1 Weight Loss Injection Market Drivers
 Table 141. GLP-1 Weight Loss Injection Market Challenges
 Table 142. GLP-1 Weight Loss Injection Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of GLP-1 Weight Loss Injection
 Figure 2. Global GLP-1 Weight Loss Injection Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global GLP-1 Weight Loss Injection Market Share by Type: 2025 & 2032
 Figure 4. Liraglutide Product Picture
 Figure 5. Semaglutide Product Picture
 Figure 6. Tirzepatide Product Picture
 Figure 7. Benaglutide Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global GLP-1 Weight Loss Injection Market Value by Application (US$ Million), 2021–2032
 Figure 10. Global GLP-1 Weight Loss Injection Market Share by Application: 2025 & 2032
 Figure 11. Hospital
 Figure 12. Clinic
 Figure 13. Others
 Figure 14. Global GLP-1 Weight Loss Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global GLP-1 Weight Loss Injection Market Size (US$ Million), 2021–2032
 Figure 16. Global GLP-1 Weight Loss Injection Sales (K Units), 2021–2032
 Figure 17. Global GLP-1 Weight Loss Injection Average Price (US$/Unit), 2021–2032
 Figure 18. GLP-1 Weight Loss Injection Report Years Considered
 Figure 19. GLP-1 Weight Loss Injection Sales Share by Manufacturers in 2025
 Figure 20. Global GLP-1 Weight Loss Injection Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global GLP-1 Weight Loss Injection Players: Market Share by Revenue in GLP-1 Weight Loss Injection in 2025
 Figure 22. GLP-1 Weight Loss Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global GLP-1 Weight Loss Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America GLP-1 Weight Loss Injection Sales Market Share by Country (2021–2032)
 Figure 25. North America GLP-1 Weight Loss Injection Revenue Market Share by Country (2021–2032)
 Figure 26. United States GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe GLP-1 Weight Loss Injection Sales Market Share by Country (2021–2032)
 Figure 29. Europe GLP-1 Weight Loss Injection Revenue Market Share by Country (2021–2032)
 Figure 30. Germany GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific GLP-1 Weight Loss Injection Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific GLP-1 Weight Loss Injection Revenue Market Share by Region (2021–2032)
 Figure 37. China GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America GLP-1 Weight Loss Injection Sales Market Share by Country (2021–2032)
 Figure 45. Latin America GLP-1 Weight Loss Injection Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa GLP-1 Weight Loss Injection Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa GLP-1 Weight Loss Injection Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE GLP-1 Weight Loss Injection Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of GLP-1 Weight Loss Injection by Type (2021–2032)
 Figure 56. Global Revenue Market Share of GLP-1 Weight Loss Injection by Type (2021–2032)
 Figure 57. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of GLP-1 Weight Loss Injection by Application (2021–2032)
 Figure 59. Global Revenue Market Share of GLP-1 Weight Loss Injection by Application (2021–2032)
 Figure 60. Global GLP-1 Weight Loss Injection Price (US$/Unit) by Application (2021–2032)
 Figure 61. GLP-1 Weight Loss Injection Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global GLP 1 Weight Loss Pill Market Research Report 2024
Global GLP 1 Weight Loss Drug Market Research Report 2024
Global GLP 1 Injection Market Research Report 2024
GLP 1 for Weight Loss Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Agonists for Obesity Market Research Report 2024
Global GLP 1 Agonists for the Treatment of both Diabetes and Obesity Market Research Report 2024
Global GLP 1 Agonist Injection Market Research Report 2024
Global GLP 1RA based Therapy for Obesity Market Research Report 2024
Global GLP 1 based Therapy Market Research Report 2024
Global Oral GLP 1 Agonist Market Research Report 2024
Global Glucagon like peptide 1 GLP 1 based Therapies Market Research Report 2025
Global Glucagon Like Peptide 1 GLP 1 Agonists Market Research Report 2025
Global Antidiabetic Glucagon like Peptide 1 Agonists Market Research Report 2025
Global GLP 1 Drug Peptide API Market Research Report 2024
Global Liraglutide for The Treatment of Diabetes and Obesity Market Research Report 2024
Global GLP 1 Injection Pen Market Research Report 2024
Global Semaglutide Injection Market Research Report 2024
GLP Analogs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
GLP 1 Analogues Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global GLP 1 Receptor Agonist Drugs Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions